AAN: Monoclonal Antibodies for MS During Breastfeeding Not Harmful
TUESDAY, March 12, 2024 -- For mothers with multiple sclerosis or neuromyelitis optica spectrum disease, receipt of monoclonal antibodies (mAb) during breastfeeding is not associated with infant hospitalization, systemic antibiotic use,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 12, 2024 Category: Pharmaceuticals Source Type: news
Christina Applegate Opens Up About the Agony of Fighting MS
TUESDAY, March 12, 2024 -- Actress Christina Applegate, who has been battling multiple sclerosis (MS) since 2021, shared her struggles with the debilitating disease on Monday. “I live kind of in hell. I’m not out a lot, so this is a little... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 12, 2024 Category: General Medicine Source Type: news
Breastfeeding While Taking MS Monoclonal Antibody Drugs Appears Safe
(MedPage Today) -- Exposure to multiple sclerosis (MS) monoclonal antibody treatment during breastfeeding appeared to have no negative effect on the early development or health of infants, registry data in Germany showed.
Over the first 3 years... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 11, 2024 Category: Neurology Source Type: news
Christina Applegate describes 'living in hell' as she shares devastating health update
Christina Applegate, 52, has been living with multiple sclerosis since she was diagnosed in 2021. She recently gave an emotional interview about her struggles with the disease (Source: Daily Express - Health)
Source: Daily Express - Health - March 11, 2024 Category: Consumer Health News Source Type: news
Christina Applegate Tells ‘GMA’ She “Lives Kind Of In Hell’ With MS, But Felt “Beloved” At Emmys
Christina Applegate, appearing upbeat, with her trademark humor in tact, nonetheless was candid in her self-assessment in an appearance on today’s Good Morning America. In her first extended interview since her 2021 diagnosis of multiple sclerosis, Applegate told host Robin Roberts, “I live kind…#christinaapplegate #goodmorningamerica #applegate #robinroberts #gma #jamielynnsigler #emmyawards #emmy (Source: Reuters: Health)
Source: Reuters: Health - March 11, 2024 Category: Consumer Health News Source Type: news
US FDA Declines to Approve Viatris's Injection for Multiple Sclerosis US FDA Declines to Approve Viatris's Injection for Multiple Sclerosis
The U.S. FDA has declined to approve Viatris and Mapi Pharma ' s once-a-month injection for treating relapsing forms of debilitating neurological condition multiple sclerosis...Reuters Health Information (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 11, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news
The Power of Patient-Reported Outcomes Inhibited by Barriers The Power of Patient-Reported Outcomes Inhibited by Barriers
Patient-reported outcomes in multiple sclerosis matter but remain underused due to multiple barriers.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 7, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news
BTK Inhibitor Fails to Eliminate Paramagnetic Rim Lesions in MS
(MedPage Today) -- WEST PALM BEACH, Fla. -- Tolebrutinib, an investigational brain-penetrant Bruton's tyrosine kinase (BTK) inhibitor, failed to eliminate paramagnetic rim lesions (PRLs) in people with multiple sclerosis (MS), a small phase IIa... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 7, 2024 Category: Neurology Source Type: news
Prognostic Value of sNfL in MS Confirmed Prognostic Value of sNfL in MS Confirmed
ASCLEPIOS sub-studies show high sNfL levels at 3 and 12 months predictive of future CNS activity in patients with multiple sclerosis.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 7, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news
Seizure Risk Nearly Double in Patients With MS Seizure Risk Nearly Double in Patients With MS
The risk for seizure is almost twofold higher in patients with multiple sclerosis than in those without MS and higher still among those taking an S1PR modulator.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 6, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news
Evobrutinib Fails to Beat Teriflunomide in Relapsing MS
(MedPage Today) -- WEST PALM BEACH, Fla. -- The investigational oral Bruton's tyrosine kinase (BTK) inhibitor evobrutinib failed to distinguish itself from teriflunomide (Aubagio) in two phase III trials of relapsing multiple sclerosis (MS) patients... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 6, 2024 Category: Neurology Source Type: news
Migraine a Forerunner of Multiple Sclerosis? Migraine a Forerunner of Multiple Sclerosis?
A common comorbidity in multiple sclerosis migraine is not part of the 3- to 5-year disease prodrome, new research suggested.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 6, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news
MS Drugs Can Be Safely Taken While Breastfeeding
TUESDAY, March 5, 2024 -- Certain drugs used to treat multiple sclerosis appear to be safe for babies if taken by breastfeeding moms, a new study finds.
Breastfed babies whose moms received monoclonal antibody treatments for MS did not develop any... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 5, 2024 Category: General Medicine Source Type: news
Frexalimab Promising for Relapsing Multiple Sclerosis Frexalimab Promising for Relapsing Multiple Sclerosis
The novel investigational second-generation anti –CD40 ligand monoclonal antibody frexalimab significantly reduced disease activity in relapsing MS in a phase 2 study.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 5, 2024 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery Source Type: news
What are the benefits and risks of drugs acting on the immune system to treat relapsing-remitting multiple sclerosis ?
Tuesday, March 5, 2024 (Source: Cochrane News and Events)
Source: Cochrane News and Events - March 5, 2024 Category: Information Technology Authors: Paolo Rosati Source Type: news
